Inari Medical Announces Strategic Partnership with VFLO Medical to Introduce Peripheral Innovation Technologies in Greater China

Dec 03, 2024 22:15 CST Updated 22:15

Inari Medical

Cardiovascular Disease Treatment Device Developer

Inari MedicalAnnouncement with Chinese EnterprisesVFLO Medical (VFLO Medical）Reached a strategic cooperation, will cooperate withVFLO Medical Establishes Joint Venture. Joint VentureWill ObtainInari MedicalIncludingClotTrieverAndFlowTrieverA series of innovative medical device products, including those within the region, have been granted distribution rights in Greater China, along with usage rights.Inari MedicalThe rights to localize production and sell in the Greater China region.

VFLO Medical is an innovative medical device company co-incubated by 6 Dimensions Capital and 120 Capital (founded in 2021). Its team consists of renowned and experienced industry professionals, aiming to create a leading medical device platform focused on providing innovative vascular therapies for patients in China.

Executive Evaluation

"This collaboration enables different types of patients and medical institutions in China to benefit from Inari's innovative products. We are excited to have reached a long-term strategic partnership with 6 Dimensions Capital and 120 Capital. Through VFLO Medical, we will continuously introduce Inari's products into the Greater China region, strengthen the vascular intervention market, and bring more benefits to patients."

---Drew Hykes, CEO of Inari Medical

"Inari is a leader in mechanical thrombectomy, and our strategic partnership holds significant importance for the current standard of care in China and is a game-changer. Like Inari, we are firmly committed to developing innovative technologies for underserved patients, and we believe we can bring meaningful improvements to the lives of patients in China suffering from venous and other vascular diseases."

---Yibo Zhu Managing Partner of Tonghe Yucheng and Director of VFLO Medical

Two Products to Be Introduced in ChinaClotTriever andFlowTriever is a classic peripheral thrombectomy product.

ClotTriever is an innovative mechanical thrombectomy device specifically developed for deep vein thrombosis, which received FDA approval for market release in 2017.
FlowTriever is the world's first device for treatingMechanical Thrombectomy System for Pulmonary Embolism, which was approved by the FDA for marketing in 2015.

Currently, ClotTriever and FlowTriever have successfully treated over 150,000 patients worldwide. Both products have entered the innovative medical device channel in China, which means they will be approved for marketing soon.

However, similar domestic products have either already been launched or are in clinical trials.For example, Tendvia from Shanghai Tendvia Medical has been approved for marketing and commercialization has begun.Once ClotTriever and FlowTriever are launched in China, they will need to compete with similar domestically produced products. It remains uncertain who will dominate the Chinese market in the future.

FlowTriever

FlowTrieverIt is the first mechanical thrombectomy system approved by the FDA for the treatment of pulmonary embolism, designed to rapidly remove blood clots and immediately improve symptoms in patients with acute pulmonary embolism.

FlowTrieverIncluding two core components: Triever Aspiration Catheter and FlowTriever Catheter.

The Trieve Aspiration Catheter is a large-lumen catheter with high trackability that can be used with large-bore syringes to quickly aspirate large amounts of thrombus while minimizing blood loss. It is available in three sizes: Triever16, Triever20, and Triever24.

The FlowTriever catheter is a catheter with three self-expanding nitinol mesh disks, available in four sizes: S (6-10 mm), M (11-14 mm), L (15-18 mm), and XL (19-25 mm). It is designed to lyse thrombus and deliver it to the Triever20.

ClotTriever

ClotTrieverIt is a mechanical thrombectomy device specifically designed for the treatment of deep vein thrombosis (DVT).

ClotTrieverConsisting of three models:

ClotTriever Catheter

The ClotTriever catheter is capable of collecting and removing thrombus (including thrombus on the vessel wall) from vessels ranging from 6-16 mm in diameter.

ClotTriever BOLD Catheter

ClotTriever BOLD Catheter Utilizes a Shortened Collection Stent and HyperClearTM Technology for Faster Operating Room Turnaround for DVT. HyperClear technology is the latest surface treatment innovation designed to reduce clot adherence within the stent, thereby improving stent clearance and reducing procedure time.

ClotTriever XL Catheter

YesClotTrieverThe largest model in the series, specifically designed for effective clearance of the cavity.Designed for thrombus in the veins.

Inari Medical

Inari MedicalIt is an innovative medical device company focused on developing products that treat patients with venous diseases and transform their lives.